← Leaderboards
Peter Como
University Of Rochester
$68,808
Attributed
$68,808
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$68,808 · 2
By mechanism
M01$68,808 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- Roger M Kurlan$13,810,390
- Ira Shoulson$11,021,025
- B. Paige Lawrence$23,471,485
- Deborah A Cory-Slechta$24,420,607
- Mark E Stanton$1,185,710
Others in their field
Top investigators on “Combination Chemotherapy”
- Charles A Coltman · Southwest Oncology Group$152,507,709
- Philip J Disaia · University Of California Irvine$115,767,092
- Norman Wolmark · Nsabp Foundation, Inc.$63,073,711
- Richard L Schilsky · University Of Chicago$54,853,416
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$47,956,689
Research focus
Combination ChemotherapyClinical ResearchHuman SubjectHuman Therapy EvaluationChild (0-11)ClonidineComorbidityHuntington'S DiseaseLactatesMagnetic Resonance ImagingMental Disorder ChemotherapyMethylphenidateNeuroprotectantsTourette'S SyndromeAttention Deficit DisorderUbiquinoneBasal GangliaBrain Disorder ChemotherapyCerebral Cortex
Grant awards (6)
TREATMENT OF ADHD IN CHILDREN WITH TOURETTE'S SYNDROME$0
M01 · FY2002 · RR
CO-ENZYME Q10 AND REMACEMIDE --EVALUATION IN HUNTINGTON'S DISEASE$0
M01 · FY2002 · RR
TREATMENT OF ADHD IN CHILDREN WITH TOURETTE'S SYNDROME$19,613
M01 · FY2001 · RR
CO-ENZYME Q10 AND REMACEMIDE --EVALUATION IN HUNTINGTON'S DISEASE$19,613
M01 · FY2001 · RR
TREATMENT OF ADHD IN CHILDREN WITH TOURETTE'S SYNDROME$14,791
M01 · FY2000 · RR
CO-ENZYME Q10 AND REMACEMIDE --EVALUATION IN HUNTINGTON'S DISEASE$14,791
M01 · FY2000 · RR